CLOs on the Move

Paycom

www.paycom.com

 
Paycom (NYSE:PAYC) helps employers streamline their payroll and HR processes with the latest cloud-based human capital management technology. We innovated payroll services over the Internet and for over a decade, our Software-as-a-Service (SaaS) solution has helped to free companies from the constraints of traditional software. In addition to payroll processing we offer a complete suite of human capital management tools that includes time and attendance, HRIS, talent acquisition, HR management and talent management all in one online application. Paycom is growing at a phenomenal pace by providing cutting-edge technology and personal payroll expertise at a lower cost. As one of ...
  • Number of Employees: 250-1000
  • Annual Revenue: $250-500 Million
  • www.paycom.com
  • 7501 W Memorial Rd
    Oklahoma City, OK USA 73142
  • Phone: 405.722.6900

Executives

Name Title Contact Details
Matthew Paque
 Executive Vice President,General Counsel Profile

Similar Companies

Gillians Foods Inc

Gillians Foods Inc is a Lynn, MA-based company in the Business Services sector.

Logmatix Inc

Logmatix Inc is a Marietta, GA-based company in the Business Services sector.

PSC Metals

PSC Metals is engaged principally in the buying, selling, and processing of both ferrous and non-ferrous scrap for its own account and for the accounts of others on a North American basis, and providing on-site mill services in partnership with some of the world's best-known and largest steel producers.

Kinco

Kinco is a Portland, OR-based company in the Business Services sector.

Mural Oncology

We know that drug development is both an art and a science. The work we do is incredibly technical, intentional, and specific, but there is an art to it - because we must leave room for creativity, innovation and spontaneity. Murals are paintings that transform overlooked or unused spaces - creating something impactful and meaningful. There remains many overlooked opportunities in cancer drug development. This is what inspires us. Our mission is simple, to create novel immunotherapies that can change patients lives so they can get back to what matters most - living. Mural Oncology is leveraging its industry-leading protein engineering platform to revolutionize cytokine-based immunotherapies for the treatment of cancer. Immunotherapies have been transformative for some people living with cancer, but unfortunately many patients still do not benefit - either because they are ineligible for treatment or they do not respond well to current therapies. We leverage our expertise in cytokine biology, immune cell modulation and our protein engineering capabilities to develop first and novel immunotherapies. Our goal is to deliver meaningful, clinical benefit across a wide range of cancers, including tumor types where immunotherapies have previously not been effective. Mural Oncology is developing a portfolio of programs to broaden the potential and reach of cytokine-based immunotherapies for the treatment of cancers. (NASDAQ: MURA)